Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
Int J Mol Sci. 2023 Nov 7;24(22):16021. doi: 10.3390/ijms242216021.
Chronic myelomonocytic leukemia (CMML) is a hematological neoplasm characterized by monocytosis, splenomegaly, thrombocytopenia, and anemia. Moreover, it is associated with mutations and, rarely, with variants. We present the case of an 84-year-old patient with persistent anemia and monocytosis. Due to the presence of dysmorphic granulocytes, monocyte atypia, and myeloid precursors in the peripheral blood cells, the patient was subjected to a bone marrow examination. The diagnosis was consistent with CMML type 2. The Hemocoagulative test showed an increase in fibrinolysis markers. Next-generation targeted sequencing showed and mutations, along with an unexpected germline missense variant, rarely encountered in CMML. The patient started Azacitidine treatment and achieved normal hemostatic process values. In conclusion, we identified a heterozygous germline mutation that, together with and variants, was responsible for the hemorrhagic manifestation.
慢性髓单核细胞白血病(CMML)是一种血液系统肿瘤,其特征为单核细胞增多、脾肿大、血小板减少和贫血。此外,它与 突变和罕见的 变体有关。我们报告了一例 84 岁患者,其持续贫血和单核细胞增多。由于外周血细胞中存在畸形粒细胞、单核细胞异型性和髓系前体,患者接受了骨髓检查。诊断符合 2 型 CMML。血凝试验显示纤维蛋白溶解标志物增加。下一代靶向测序显示 和 突变,以及在 CMML 中很少见的意外 种系错义变异。患者开始接受阿扎胞苷治疗,并达到正常止血过程值。总之,我们发现了一个杂合种系突变,它与 和 变体一起,导致了出血表现。